top of page
SERVICES
CUSTOM TMA
ROUTINE PATHOLOGY
IHC / IMMUNOFLUORESCENCE
ISH / FISH
CONTRACTED SERVICES
PRIMARY IHC ANTIBODIES
PATHOLOGY FIELD
Hermatopathology
DETECTION SYSTEMS
ANCILLARIES
CONTROL TMA
OVC1501
Ovary cancer tissue array, set 1, non-overlapping with OVC1502, 150 cores from normal/benign (5 cases) and cancer (70 cases with grading and TNM staging data) tissues in duplicates
Price per slide:
$289
Species:
Human
Cases:
75
Cores:
150
Core Size:
1.1mm
Core Thickness:
4um
Rows:
10
Columns:
15
Format:
Intended Usage:
For research use only. Designed for IHC or ISH based protein or RNA tissue profiling in ovary cancers.
10
X
15
For illustration purpose only. Actual product may vary.
Notes:
All the tissues were fixed in 10% neutral buffered formalin for 24 hours and processed using identical SOPs. Sections were picked onto Superfrost Plus or APES coated Superfrost slides. They can be stored for use at 4C for up to six months from the date of shipment. There may be 5 to 10% of tissue core loss.
Bake at 60C for ~60 minutes before use. If antigen retrieving is needed, it is important to avoid direct-boiling and high pH or high strength antigen retrieving buffer. For availability of complimentary IHC data, please contact us at info@pantomics.com.
ARRAY POSITION | IMAGE | SEX | AGE | ANATOMIC SITE | PATHOLOGY | NATURE | GRADE | STAGE (TNM) |
|---|---|---|---|---|---|---|---|---|
A01 |  | F | 40 | Ovary | Normal | Normal | ||
A02 |  | F | 40 | Ovary | Normal | Normal | ||
A03 |  | F | 19 | Ovary | Mucinous cystadenoma | Benign | ||
A04 |  | F | 35 | Ovary | Thecoma | Benign | ||
A05 |  | F | 42 | Ovary | Borderline serous cystadenoma | Benign | ||
A06 |  | F | 53 | Ovary | Serous cystadenocarcinoma | Malignant | III | T3N0M1 |
A07 |  | F | 56 | Ovary | Serous cystadenocarcinoma | Malignant | II~III | T3N0M1 |
A08 |  | F | 40 | Ovary | Metastatic colon signet ring cell carcinoma | Metastasis | ||
A09 |  | F | 58 | Ovary | Serous cystadenocarcinoma | Malignant | II~III | T3N0M1 |
A10 |  | F | 50 | Ovary | Endometrioid adenocarcinoma | Malignant | II~III | T3N0M1 |
A11 |  | F | 65 | Ovary | Serous cystadenocarcinoma | Malignant | I | T1N0M0 |
A12 |  | F | 42 | Ovary | Endometrioid adenocarcinoma | Malignant | III | T2N0M0 |
A13 |  | F | 29 | Ovary | Endometrioid adenocarcinoma | Malignant | II | T1N0M0 |
A14 |  | F | 51 | Ovary | Endometrioid adenocarcinoma | Malignant | III | T1N0M0 |
A15 |  | F | 20 | Ovary | Serous cystadenocarcinoma | Malignant | I~II | T1N0M0 |
B01 |  | F | 40 | Ovary | Normal | Normal | ||
B02 |  | F | 40 | Ovary | Normal | Normal | ||
B03 |  | F | 19 | Ovary | Mucinous cystadenoma | Benign | ||
B04 |  | F | 35 | Ovary | Thecoma | Benign | ||
B05 |  | F | 42 | Ovary | Borderline serous cystadenoma | Benign | ||
B06 |  | F | 53 | Ovary | Serous cystadenocarcinoma | Malignant | III | T3N0M1 |
B07 |  | F | 56 | Ovary | Serous cystadenocarcinoma | Malignant | II~III | T3N0M1 |
B08 |  | F | 40 | Ovary | Metastatic colon signet ring cell carcinoma | Metastasis | ||
B09 |  | F | 58 | Ovary | Serous cystadenocarcinoma | Malignant | II~III | T3N0M1 |
B10 |  | F | 50 | Ovary | Endometrioid adenocarcinoma | Malignant | II~III | T3N0M1 |
B11 |  | F | 65 | Ovary | Serous cystadenocarcinoma | Malignant | I | T1N0M0 |
B12 |  | F | 42 | Ovary | Endometrioid adenocarcinoma | Malignant | III | T2N0M0 |
B13 |  | F | 29 | Ovary | Endometrioid adenocarcinoma | Malignant | II | T1N0M0 |
B14 |  | F | 51 | Ovary | Endometrioid adenocarcinoma | Malignant | III | T1N0M0 |
B15 |  | F | 20 | Ovary | Serous cystadenocarcinoma | Malignant | I~II | T1N0M0 |
C01 |  | F | 47 | Ovary | Serous cystadenocarcinoma | Malignant | III | T1N0M0 |
C02 |  | F | 53 | Ovary | Serous cystadenocarcinoma | Malignant | III | T2N0M0 |
C03 |  | F | 48 | Ovary | Endometrioid adenocarcinoma | Malignant | III | T1N0M0 |
C04 |  | F | 44 | Ovary | Endometrioid adenocarcinoma | Malignant | II~III | T1N0M0 |
C05 |  | F | 51 | Ovary | Serous cystadenocarcinoma | Malignant | III | T3N1M1 |
C06 |  | F | 65 | Ovary | Endometrioid adenocarcinoma | Malignant | II~III | T1N0M0 |
C07 |  | F | 43 | Ovary | Serous cystadenocarcinoma | Malignant | III | T1N0M0 |
C08 |  | F | 45 | Ovary | Serous cystadenocarcinoma | Malignant | II | T3N1M0 |
C09 |  | F | 82 | Ovary | Endometrioid adenocarcinoma | Malignant | II | T1N0M0 |
C10 |  | F | 47 | Ovary | Mucinous cystadenocarcinoma | Malignant | I | T3N1M0 |
C11 |  | F | 43 | Ovary | Mucinous cystadenocarcinoma | Malignant | III | T2N0M0 |
C12 |  | F | 63 | Ovary | Endometrioid adenocarcinoma | Malignant | III | T2N0M0 |
C13 |  | F | 54 | Ovary | Endometrioid adenocarcinoma | Malignant | III | T2N0M0 |
C14 |  | F | 56 | Ovary | Serous cystadenocarcinoma | Malignant | I | T1N0M0 |
C15 |  | F | 34 | Ovary | Serous cystadenocarcinoma | Malignant | I | T2N0M0 |
D01 |  | F | 47 | Ovary | Serous cystadenocarcinoma | Malignant | III | T1N0M0 |
D02 |  | F | 53 | Ovary | Serous cystadenocarcinoma | Malignant | III | T2N0M0 |
D03 |  | F | 48 | Ovary | Endometrioid adenocarcinoma | Malignant | III | T1N0M0 |
D04 |  | F | 44 | Ovary | Endometrioid adenocarcinoma | Malignant | II~III | T1N0M0 |
D05 |  | F | 51 | Ovary | Serous cystadenocarcinoma | Malignant | III | T3N1M1 |
D06 |  | F | 65 | Ovary | Endometrioid adenocarcinoma | Malignant | II~III | T1N0M0 |
D07 |  | F | 43 | Ovary | Serous cystadenocarcinoma | Malignant | III | T1N0M0 |
D08 |  | F | 45 | Ovary | Serous cystadenocarcinoma | Malignant | II | T3N1M0 |
D09 |  | F | 82 | Ovary | Endometrioid adenocarcinoma | Malignant | II | T1N0M0 |
D10 |  | F | 47 | Ovary | Mucinous cystadenocarcinoma | Malignant | I | T3N1M0 |
D11 |  | F | 43 | Ovary | Mucinous cystadenocarcinoma | Malignant | III | T2N0M0 |
D12 |  | F | 63 | Ovary | Endometrioid adenocarcinoma | Malignant | III | T2N0M0 |
D13 |  | F | 54 | Ovary | Endometrioid adenocarcinoma | Malignant | III | T2N0M0 |
D14 |  | F | 56 | Ovary | Serous cystadenocarcinoma | Malignant | I | T1N0M0 |
D15 |  | F | 34 | Ovary | Serous cystadenocarcinoma | Malignant | I | T2N0M0 |
E01 |  | F | 24 | Ovary | Mucinous cystadenocarcinoma | Malignant | I | T1N0M0 |
E02 |  | F | 58 | Ovary | Endometrioid adenocarcinoma | Malignant | III | T2N0M0 |
E03 |  | F | 25 | Ovary | Endometrioid adenocarcinoma | Malignant | II | T1N0M0 |
E04 |  | F | 51 | Ovary | Endometrioid adenocarcinoma | Malignant | I | T1N0M0 |
E05 |  | F | 25 | Ovary | Mucinous cystadenocarcinoma | Malignant | I | T1N0M0 |
E06 |  | F | 50 | Ovary | Endometrioid adenocarcinoma | Malignant | I | T3N1M1 |
E07 |  | F | 40 | Ovary | Endodermal sinus tumor | Malignant | T1N0M0 | |
E08 |  | F | 34 | Ovary | Endodermal sinus tumor | Malignant | T3N0M1 | |
E09 |  | F | 33 | Ovary | Serous cystadenocarcinoma | Malignant | I | T1N0M0 |
E10 |  | F | 52 | Ovary | Endometrioid adenocarcinoma | Malignant | III | T3N0M0 |
E11 |  | F | 42 | Ovary | Endometrioid adenocarcinoma | Malignant | I | T3N0M1 |
E12 |  | F | 68 | Ovary | Endometrioid adenocarcinoma | Malignant | III | T3N1M0 |
E13 |  | F | 17 | Ovary | Endometrioid adenocarcinoma | Malignant | I | T1N0M0 |
E14 |  | F | 38 | Ovary | Mucinous cystadenocarcinoma | Malignant | I | T1N1M0 |
E15 |  | F | 48 | Ovary | Mucinous cystadenocarcinoma | Malignant | III | T1N0M0 |
F01 |  | F | 24 | Ovary | Mucinous cystadenocarcinoma | Malignant | I | T1N0M0 |
F02 |  | F | 58 | Ovary | Endometrioid adenocarcinoma | Malignant | III | T2N0M0 |
F03 |  | F | 25 | Ovary | Endometrioid adenocarcinoma | Malignant | II | T1N0M0 |
F04 |  | F | 51 | Ovary | Endometrioid adenocarcinoma | Malignant | I | T1N0M0 |
F05 |  | F | 25 | Ovary | Mucinous cystadenocarcinoma | Malignant | I | T1N0M0 |
F06 |  | F | 50 | Ovary | Endometrioid adenocarcinoma | Malignant | I | T3N1M1 |
F07 |  | F | 40 | Ovary | Endodermal sinus tumor | Malignant | T1N0M0 | |
F08 |  | F | 34 | Ovary | Endodermal sinus tumor | Malignant | T3N0M1 | |
F09 |  | F | 33 | Ovary | Serous cystadenocarcinoma | Malignant | I | T1N0M0 |
F10 |  | F | 52 | Ovary | Endometrioid adenocarcinoma | Malignant | III | T3N0M0 |
F11 |  | F | 42 | Ovary | Endometrioid adenocarcinoma | Malignant | I | T3N0M1 |
F12 |  | F | 68 | Ovary | Endometrioid adenocarcinoma | Malignant | III | T3N1M0 |
F13 |  | F | 17 | Ovary | Endometrioid adenocarcinoma | Malignant | I | T1N0M0 |
F14 |  | F | 38 | Ovary | Mucinous cystadenocarcinoma | Malignant | I | T1N1M0 |
F15 |  | F | 48 | Ovary | Mucinous cystadenocarcinoma | Malignant | III | T1N0M0 |
G01 |  | F | 18 | Ovary | Serous cystadenocarcinoma | Malignant | II | T1N0M0 |
G02 |  | F | 36 | Ovary | Leimyosarcoma? | Malignant | T1N0M0 | |
G03 |  | F | 42 | Ovary | Serous cystadenocarcinoma | Malignant | II~III | T2N0M0 |
G04 |  | F | 42 | Ovary | Serous cystadenocarcinoma | Malignant | II~III | T3N0M1 |
G05 |  | F | 23 | Ovary | Endodermal sinus tumor | Malignant | ||
G06 |  | F | 45 | Ovary | Serous cystadenocarcinoma | Malignant | III | T2N0M0 |
G07 |  | F | 18 | Ovary | Mucinous cystadenocarcinoma | Malignant | I | T1N0M0 |
G08 |  | F | 48 | Ovary | Serous cystadenocarcinoma | Malignant | II | T1N0M0 |
G09 |  | F | 49 | Ovary | Endometrioid adenocarcinoma | Malignant | III | T1N0M0 |
G10 |  | F | 51 | Ovary | Endometrioid adenocarcinoma | Malignant | III | T1N0M0 |
G11 |  | F | 48 | Ovary | Mucinous cystadenocarcinoma | Malignant | I | T1N0M0 |
G12 |  | F | 43 | Ovary | Granulosa cell tumor | Benign | ||
G13 |  | F | 51 | Ovary | Serous cystadenocarcinoma | Malignant | III | T1N0M0 |
G14 |  | F | 71 | Ovary | Endometrioid adenocarcinoma | Malignant | III | T3N0M1 |
G15 |  | F | 58 | Ovary | Endometrioid adenocarcinoma | Malignant | III | T3N0M1 |
H01 |  | F | 18 | Ovary | Serous cystadenocarcinoma | Malignant | II | T1N0M0 |
H02 |  | F | 36 | Ovary | Leimyosarcoma? | Malignant | T1N0M0 | |
H03 |  | F | 42 | Ovary | Serous cystadenocarcinoma | Malignant | II~III | T2N0M0 |
H04 |  | F | 42 | Ovary | Serous cystadenocarcinoma | Malignant | II~III | T3N1M1 |
H05 |  | F | 23 | Ovary | Endodermal sinus tumor | Malignant | ||
H06 |  | F | 45 | Ovary | Serous cystadenocarcinoma | Malignant | III | T2N0M0 |
H07 |  | F | 18 | Ovary | Mucinous cystadenocarcinoma | Malignant | I | T1N0M0 |
H08 |  | F | 48 | Ovary | Serous cystadenocarcinoma | Malignant | II | T1N0M0 |
H09 |  | F | 49 | Ovary | Endometrioid adenocarcinoma | Malignant | III | T1N0M0 |
H10 |  | F | 51 | Ovary | Endometrioid adenocarcinoma | Malignant | III | T1N0M0 |
H11 |  | F | 48 | Ovary | Mucinous cystadenocarcinoma | Malignant | I | T1N0M0 |
H12 |  | F | 43 | Ovary | Granulosa cell tumor | Benign | T1N0M0 | |
H13 |  | F | 51 | Ovary | Serous cystadenocarcinoma | Malignant | III | T1N0M0 |
H14 |  | F | 71 | Ovary | Endometrioid adenocarcinoma | Malignant | III | T3N0M1 |
H15 |  | F | 58 | Ovary | Endometrioid adenocarcinoma | Malignant | III | T3N0M1 |
I01 |  | F | 17 | Ovary | Dysgerminoma | Malignant | ||
I02 |  | F | 50 | Ovary | Endometrioid adenocarcinoma | Malignant | III | T1N0M0 |
I03 |  | F | 44 | Ovary | Serous cystadenocarcinoma | Malignant | III | T2N0M0 |
I04 |  | F | 54 | Ovary | Serous cystadenocarcinoma | Malignant | II~III | T3N1M1 |
I05 |  | F | 39 | Ovary | Mucinous cystadenocarcinoma | Malignant | I | T3N0M1 |
I06 |  | F | 39 | Ovary | Endometrioid adenocarcinoma | Malignant | III | T2N0M0 |
I07 |  | F | 53 | Ovary | Mucinous cystadenocarcinoma | Malignant | II | T1N0M0 |
I08 |  | F | 43 | Ovary | Endometrioid adenocarcinoma | Malignant | I | T1N0M0 |
I09 |  | F | 74 | Ovary | Serous cystadenocarcinoma | Malignant | III | T1N0M0 |
I10 |  | F | 52 | Ovary | Endometrioid adenocarcinoma | Malignant | II | T1N0M0 |
I11 |  | F | 56 | Ovary | Serous cystadenocarcinoma | Malignant | III | T3N0M1 |
I12 |  | F | 54 | Ovary | Endometrioid adenocarcinoma | Malignant | III | T3N0M1 |
I13 |  | F | 54 | Ovary | Serous cystadenocarcinoma | Malignant | III | T3N0M1 |
I14 |  | F | 23 | Ovary | Mucinous cystadenocarcinoma | Malignant | I~II | T1N0M0 |
I15 |  | F | 52 | Ovary | Clear cell carcinoma | Malignant | II | T1N0M0 |
J01 |  | F | 17 | Ovary | Dysgerminoma | Malignant | ||
J02 |  | F | 50 | Ovary | Endometrioid adenocarcinoma | Malignant | III | T1N0M0 |
J03 |  | F | 44 | Ovary | Serous cystadenocarcinoma | Malignant | III | T2N0M0 |
J04 |  | F | 54 | Ovary | Serous cystadenocarcinoma | Malignant | II~III | T3N1M1 |
J05 |  | F | 39 | Ovary | Mucinous cystadenocarcinoma | Malignant | I | T3N0M1 |
J06 |  | F | 39 | Ovary | Endometrioid adenocarcinoma | Malignant | III | T2N0M0 |
J07 |  | F | 53 | Ovary | Mucinous cystadenocarcinoma | Malignant | II | T1N0M0 |
J08 |  | F | 43 | Ovary | Endometrioid adenocarcinoma | Malignant | I | T1N0M0 |
J09 |  | F | 74 | Ovary | Serous cystadenocarcinoma | Malignant | III | T1N0M0 |
J10 |  | F | 52 | Ovary | Endometrioid adenocarcinoma | Malignant | II | T1N0M0 |
J11 |  | F | 56 | Ovary | Serous cystadenocarcinoma | Malignant | III | T3N0M1 |
J12 |  | F | 54 | Ovary | Endometrioid adenocarcinoma | Malignant | III | T3N0M1 |
J13 |  | F | 54 | Ovary | Serous cystadenocarcinoma | Malignant | III | T3N0M1 |
J14 |  | F | 23 | Ovary | Mucinous cystadenocarcinoma | Malignant | I~II | T1N0M0 |
J15 |  | F | 52 | Ovary | Clear cell carcinoma | Malignant | II | T1N0M0 |
bottom of page